Gülçin Tezcan

1.2k total citations
64 papers, 828 citations indexed

About

Gülçin Tezcan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gülçin Tezcan has authored 64 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 22 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Gülçin Tezcan's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (9 papers) and Inflammasome and immune disorders (8 papers). Gülçin Tezcan is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (9 papers) and Inflammasome and immune disorders (8 papers). Gülçin Tezcan collaborates with scholars based in Türkiye, Russia and United States. Gülçin Tezcan's co-authors include Berrin Tunca, Ünal Egelí, Gülşah Çeçener, Seçil Ak, Şahsine Tolunay, Svetlana F. Khaiboullina, Albert A. Rizvanov, Alan McIntyre, Ferah Budak and Ahmet Bekâr and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Gülçin Tezcan

61 papers receiving 817 citations

Peers

Gülçin Tezcan
Zhi‐Hong Zheng China
Qin Fu China
Maryam Rezaei Iran
Hongpeng He China
Chao Zeng China
Lin Cao China
Michael J. Graziano United States
Zhi‐Hong Zheng China
Gülçin Tezcan
Citations per year, relative to Gülçin Tezcan Gülçin Tezcan (= 1×) peers Zhi‐Hong Zheng

Countries citing papers authored by Gülçin Tezcan

Since Specialization
Citations

This map shows the geographic impact of Gülçin Tezcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülçin Tezcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülçin Tezcan more than expected).

Fields of papers citing papers by Gülçin Tezcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülçin Tezcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülçin Tezcan. The network helps show where Gülçin Tezcan may publish in the future.

Co-authorship network of co-authors of Gülçin Tezcan

This figure shows the co-authorship network connecting the top 25 collaborators of Gülçin Tezcan. A scholar is included among the top collaborators of Gülçin Tezcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülçin Tezcan. Gülçin Tezcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tezcan, Gülçin. (2025). Empagliflozin Inhibits OSCC Proliferation and Migration by Suppressing SLC2A3 and NLRP3. Bursa Uludag University - AVESIS. 13(3). 302–310. 1 indexed citations
2.
Garanina, Ekaterina, et al.. (2024). Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer. Pharmaceuticals. 17(3). 299–299. 5 indexed citations
3.
Ocak, Pınar Eser, Gülçin Tezcan, Fatma Nur Parın, et al.. (2024). A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiber. Asian Journal of Pharmaceutical Sciences. 19(6). 100971–100971. 1 indexed citations
4.
5.
Tezcan, Gülçin, Seçil Ak Aksoy, Hasan Kocaelı, et al.. (2023). Concurrent presence of diabetes affects the GLUT3 programming of glucose metabolism in glioblastoma.. PubMed. 27(17). 8110–8118. 1 indexed citations
6.
Çağan, Eren, Gülçin Tezcan, Ali Aşan, et al.. (2022). The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis. Viral Immunology. 35(4). 318–327. 7 indexed citations
7.
Aksoy, Seçil Ak, Gülçin Tezcan, Berrin Tunca, et al.. (2021). DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer. Genetic Testing and Molecular Biomarkers. 25(4). 276–283. 2 indexed citations
8.
Akalın, Halis, et al.. (2020). Roles of novel IL-1 family (IL-36, IL-37, and IL-38) members in chronic brucellosis. Cytokine. 135. 155211–155211. 9 indexed citations
9.
Tezcan, Gülçin, Berrin Tunca, Ahmet Bekâr, et al.. (2019). Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract. Human & Experimental Toxicology. 38(9). 1102–1110. 15 indexed citations
10.
Çetintaş, Sibel, et al.. (2018). Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study. Bosnian Journal of Basic Medical Sciences. 19(2). 172–179. 1 indexed citations
11.
Budak, Ferah, et al.. (2018). The microRNA expression signature of CD4+ T cells in the transition of brucellosis into chronicity. PLoS ONE. 13(6). e0198659–e0198659. 10 indexed citations
12.
Ak, Seçil, Gamze Güney Eskiler, Elif Ertürk, et al.. (2016). Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.. PubMed. 17(9). 4241–4246. 23 indexed citations
13.
Egelí, Ünal, Gülçin Tezcan, Gülşah Çeçener, et al.. (2016). miR-216b Targets FGFR1 and Confers Sensitivity to Radiotherapy in Pancreatic Ductal Adenocarcinoma Patients Without EGFR or KRAS Mutation. Pancreas. 45(9). 1294–1302. 15 indexed citations
14.
Ilhan‐Mutlu, Aysegül, Gülçin Tezcan, Sebastian F. Schoppmann, et al.. (2015). microRNA-21 Expression is Elevated in Esophageal Adenocarcinoma After Neoadjuvant Chemotherapy. Cancer Investigation. 33(6). 246–250. 8 indexed citations
15.
Çeçener, Gülşah, Ünal Egelí, Berrin Tunca, et al.. (2014). BRCA1/2Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients. Cancer Investigation. 32(8). 375–387. 19 indexed citations
16.
Tezcan, Gülçin, et al.. (2013). Okul öncesinde geri dönüşüm kavramı aile katılımlı proje tabanlı bir program örneği. 2(2). 2 indexed citations
17.
Ak, Seçil, Berrin Tunca, Tuncay Yılmazlar, et al.. (2013). Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients. Journal of Surgical Research. 185(2). 626–637. 9 indexed citations
18.
Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.. PubMed. 98(2). 243–51. 11 indexed citations
19.
Çeçener, Gülşah, Berrin Tunca, Ünal Egelí, et al.. (2011). The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma. Cellular and Molecular Neurobiology. 32(2). 237–244. 20 indexed citations
20.
Onaran, İlhan, et al.. (2008). The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients. Rheumatology International. 29(7). 797–800. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Hong Zheng Breakdown of academic impact, for papers by Qin Fu Breakdown of academic impact, for papers by Maryam Rezaei Breakdown of academic impact, for papers by Hongpeng He Breakdown of academic impact, for papers by Chao Zeng Breakdown of academic impact, for papers by Lin Cao Breakdown of academic impact, for papers by Michael J. Graziano
Rankless by CCL
2026